LJP 394 Toleragen: LJPC has enrolled 200 patients with lupus in its North American placebo-controlled Phase II/III trial

By WIR Staff | Oct 12, 1998 | 7:00 AM GMT

La Jolla Pharmaceutical Co. (LJPC), San Diego, Calif.
Product:

Read the full 95 word article

How to gain access

Continue reading with a
two-week free trial.